ChemicalBook > CAS DataBase List > 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide

5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide

Product Name
5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide
CAS No.
56290-94-9
Chemical Name
5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide
Synonyms
RMI-81968;Medroxalol;Medroxalol (Mixture of Diastereomers);5-[2-[4-(1,3-benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamide;5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide;5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxybenzamide;Benzamide, 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxy-
CBNumber
CB0919906
Molecular Formula
C20H24N2O5
Formula Weight
372.42
MOL File
56290-94-9.mol
More
Less

5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide Property

storage temp. 
Store at -20°C
solubility 
soluble in No data available
form 
Solid
color 
Off-white to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
M203540
Product name
Medroxalol
Packaging
250mg
Price
$1260
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0011852
Product name
MEDROXALOL
Purity
95.00%
Packaging
5MG
Price
$504.53
Updated
2021/12/16
Medical Isotopes, Inc.
Product number
41250
Product name
Medroxalol
Packaging
250mg
Price
$2200
Updated
2021/12/16
More
Less

5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide Chemical Properties,Usage,Production

Uses

Antihypertensive.

Uses

Medroxalol is an antihypertensive agent that possesses both alpha and beta-adrenergic antagonistic properties. Medroxalol is used to treat mild and moderate hypertension.

Definition

ChEBI: Medroxalol is a member of salicylamides.

in vivo

Medroxalol (oral gavage; 12.5-50 mg/kg; once daily; 12 d) treatment shows antihypertensive activity in spontaneously hypertensive rats[1].

Animal Model:Male spontaneously hypertensive rats (SHR)[1]
Dosage:12.5, 25, or 50 mg/kg
Administration:Oral gavage; 12.5, 25, or 50 mg/kg; once daily; 12 days
Result:Produced a dose-related fall in blood pressure.

5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide Suppliers

TargetMol Chemicals Inc.
Tel
+17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
19962
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
52923
Advantage
58
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
2A PharmaChem USA
Tel
--
Fax
--
Email
sales@2apharmachem.com
Country
United States
ProdList
6137
Advantage
39
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47

56290-94-9, 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide Related Search:


  • 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide
  • Medroxalol
  • 5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxybenzamide
  • RMI-81968
  • 5-[2-[4-(1,3-benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamide
  • Benzamide, 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxy-
  • Medroxalol (Mixture of Diastereomers)
  • 56290-94-9
  • C20H24N2O5